CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Collagenase clostridium histolyticum

Last Updated: August 30, 2012
Result type: Reports
Project Number: SR0287-000
Product Line: Reimbursement Review

Generic Name: Collagenase clostridium histolyticum

Brand Name: Xiaflex

Manufacturer: Auxilium Pharmaceuticals, Inc. & Actelion Pharmaceuticals Canada Inc.

Therapeutic Area: Dupuytren’s contracture

Indications: Dupuytren’s contracture with a palpable cord

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 27, 2013

Recommendation Type: List with criteria/condition